Company Name:Acceleron Pharma Inc.
CEO: Habib J. Dable

Sector: Healthcare
Industry:Biotechnology

Exchange: NASDAQ Global Market

Country: USA

Description: Acceleron Pharma Inc is a biotechnology company which focuses on discovery, development, and commercialization of novel therapies. It aims to discover key natural regulators of cellular growth and repair.


Key numbers

Market Capitalization:2365864740
Shares Outstanding: 53082000
Float: 44932585.95
Next Earning Date:2020-02-25
TTm EPS: -2.6926
TTm Dividend Rate:
200 days moving average:42.74
50 days moving average: 42.71
One day percent Change: 0.81



2018-03-31, 2018-06-30, 2018-09-30, 2018-12-31,
2018-03-31, 2018-06-30, 2018-09-30, 2018-12-31,
2015-12-31, 2016-12-31, 2017-12-31, 2018-12-31,
2015-12-31, 2016-12-31, 2017-12-31, 2018-12-31,